HSV encephalitis triggered anti-NMDAR encephalitis: a case report

go back to reference Dalmau J, Tüzün E, Wu H-y, Masjuan J, Rossi JE, Voloschin A, Baehring JM, Shimazaki H, Koide R, King D, Mason W, Sansing LH, Dichter MA, Rosenfeld MR, Lynch DR (2007) Paraneoplastic anti-N-methyl-D-aspartate receptor encephalitis associated with ovarian teratoma. Ann Neurol 61:25–36CrossRef Dalmau J, Tüzün E, Wu H-y, Masjuan J, Rossi JE, Voloschin A, Baehring JM, Shimazaki H, Koide R, King D, Mason W, Sansing LH, Dichter MA, Rosenfeld MR, Lynch DR (2007) Paraneoplastic anti-N-methyl-D-aspartate receptor encephalitis associated with ovarian teratoma. Ann Neurol 61:25–36CrossRef

go back to reference Dalmau J, Lancaster E, Martinez-Hernandez E, Rosenfeld MR, Balice-Gordon R (2011) Clinical experience and laboratory investigations in patients with anti-NMDAR encephalitis. Lancet Neurol 10:63–74CrossRef Dalmau J, Lancaster E, Martinez-Hernandez E, Rosenfeld MR, Balice-Gordon R (2011) Clinical experience and laboratory investigations in patients with anti-NMDAR encephalitis. Lancet Neurol 10:63–74CrossRef

go back to reference Lynch DR, Rattelle A, Dong YN, Roslin K, Gleichman AJ, Panzer JA (2018) Anti-NMDA receptor encephalitis: clinical features and basic mechanism. Adv Pharmacol 82:235–260CrossRef Lynch DR, Rattelle A, Dong YN, Roslin K, Gleichman AJ, Panzer JA (2018) Anti-NMDA receptor encephalitis: clinical features and basic mechanism. Adv Pharmacol 82:235–260CrossRef

go back to reference Dalmau J, Gleichman AJ, Hughes EG, Rossi JE, Peng X, Lai M, Dessain SK, Rosenfeld MR, Balice-Gordon R, Lynch DR (2008) Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies. Lancet Neurol 7:1091–1098CrossRef Dalmau J, Gleichman AJ, Hughes EG, Rossi JE, Peng X, Lai M, Dessain SK, Rosenfeld MR, Balice-Gordon R, Lynch DR (2008) Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies. Lancet Neurol 7:1091–1098CrossRef

go back to reference Graus F, Titulaer MJ, Balu R, Benseler S, Bien CG, Cellucci T, Cortese I, Dale RC, Gelfand JM, Geschwind M, Glaser CA, Honnorat J, Höftberger R, Iizuka T, Irani SR, Lancaster E, Leypoldt F, Prüss H, Rae-Grant A, Reindl M, Rosenfeld MR, Rostásy K, Saiz A, Venkatesan A, Vincent A, Wandinger KP, Waters P, Dalmau J (2016) A clinical approach to diagnosis of autoimmune encephalitis. Lancet Neurol 15:391–404CrossRef Graus F, Titulaer MJ, Balu R, Benseler S, Bien CG, Cellucci T, Cortese I, Dale RC, Gelfand JM, Geschwind M, Glaser CA, Honnorat J, Höftberger R, Iizuka T, Irani SR, Lancaster E, Leypoldt F, Prüss H, Rae-Grant A, Reindl M, Rosenfeld MR, Rostásy K, Saiz A, Venkatesan A, Vincent A, Wandinger KP, Waters P, Dalmau J (2016) A clinical approach to diagnosis of autoimmune encephalitis. Lancet Neurol 15:391–404CrossRef

go back to reference Peng Y, Liu X, Pan S, Xie Z, Wang H (2017) Anti-N-methyl-D-aspartate receptor encephalitis associated with intracranial Angiostrongylus cantonensis infection: a case report. Neurol Sci 38:703–706CrossRef Peng Y, Liu X, Pan S, Xie Z, Wang H (2017) Anti-N-methyl-D-aspartate receptor encephalitis associated with intracranial Angiostrongylus cantonensis infection: a case report. Neurol Sci 38:703–706CrossRef

go back to reference Martinez HR, Olguin-Ramirez LA, Camara-Lemarroy CR (2018) Lyme borreliosis as a trigger for NMDA receptor encephalitis? Neurol Sci 39:1815–1817CrossRef Martinez HR, Olguin-Ramirez LA, Camara-Lemarroy CR (2018) Lyme borreliosis as a trigger for NMDA receptor encephalitis? Neurol Sci 39:1815–1817CrossRef

go back to reference Iizuka T, Sakai F, Ide T, Monzen T, Yoshii S, Iigaya M, Suzuki K, Lynch DR, Suzuki N, Hata T, Dalmau J (2008) Anti-NMDA receptor encephalitis in Japan: long-term outcome without tumor removal. Neurology 70:504–511CrossRef Iizuka T, Sakai F, Ide T, Monzen T, Yoshii S, Iigaya M, Suzuki K, Lynch DR, Suzuki N, Hata T, Dalmau J (2008) Anti-NMDA receptor encephalitis in Japan: long-term outcome without tumor removal. Neurology 70:504–511CrossRef

go back to reference Viaccoz A, Desestret V, Ducray F, Picard G, Cavillon G, Rogemond V, Antoine JC, Delattre JY, Honnorat J (2014) Clinical specificities of adult male patients with NMDA receptor antibodies encephalitis. Neurology 82:556–563CrossRef Viaccoz A, Desestret V, Ducray F, Picard G, Cavillon G, Rogemond V, Antoine JC, Delattre JY, Honnorat J (2014) Clinical specificities of adult male patients with NMDA receptor antibodies encephalitis. Neurology 82:556–563CrossRef

go back to reference Nosadini M, Mohammad SS, Corazza F, Ruga EM, Kothur K, Perilongo G, Frigo AC, Toldo I, Dale RC, Sartori S (2017) Herpes simplex virus-induced anti-N-methyl-d-aspartate receptor encephalitis: a systematic literature review with analysis of 43 cases. Dev Med Child Neurol 59:796–805CrossRef Nosadini M, Mohammad SS, Corazza F, Ruga EM, Kothur K, Perilongo G, Frigo AC, Toldo I, Dale RC, Sartori S (2017) Herpes simplex virus-induced anti-N-methyl-d-aspartate receptor encephalitis: a systematic literature review with analysis of 43 cases. Dev Med Child Neurol 59:796–805CrossRef

go back to reference Leypoldt F, Titulaer MJ, Aguilar E, Walther J, Bönstrup M, Havemeister S, Teegen B, Lütgehetmann M, Rosenkranz M, Magnus T, Dalmau J (2013) Herpes Simplex virus-1 Encephalitis Can Trigger anti-NMDA Receptor Encephalitis Case Report. Neurology 81:1637–1639CrossRef Leypoldt F, Titulaer MJ, Aguilar E, Walther J, Bönstrup M, Havemeister S, Teegen B, Lütgehetmann M, Rosenkranz M, Magnus T, Dalmau J (2013) Herpes Simplex virus-1 Encephalitis Can Trigger anti-NMDA Receptor Encephalitis Case Report. Neurology 81:1637–1639CrossRef

go back to reference Armangue T, Spatola M, Vlagea A, Mattozzi S, Cárceles-Cordon M, Martinez-Heras E, Llufriu S, Muchart J, Erro ME, Abraira L, Moris G, Monros-Giménez L, Corral-Corral Í, Montejo C, Toledo M, Bataller L, Secondi G, Ariño H, Martínez-Hernández E, Juan M, Marcos MA, Alsina L, Saiz A, Rosenfeld MR, Graus F, Dalmau J, Aguilera-Albesa S, Amado-Puentes A, Arjona-Padillo A, Arrabal L, Arratibel I, Aznar-Laín G, Bellas-Lamas P, Bermejo T, Boyero-Durán S, Camacho A, Campo A, Campos D, Cantarín-Extremera V, Carnero C, Conejo-Moreno D, Dapena M, Dacruz-Álvarez D, Delgadillo-Chilavert V, Deyà A, Estela-Herrero J, Felipe A, Fernández-Cooke E, Fernández-Ramos J, Fortuny C, García-Monco JC, Gili T, González-Álvarez V, Guerri R, Guillén S, Hedrera-Fernández A, López M, López-Laso E, Lorenzo-Ruiz M, Madruga M, Málaga-Diéguez I, Martí-Carrera I, Martínez-Lacasa X, Martín-Viota L, Martín Gil L, Martínez-González MJ, Moreira A, Miranda-Herrero MC, Monge L, Muñoz-Cabello B, Navarro-Morón J, Neth O, Noguera-Julian A, Nuñez-Enamorado N, Pomar V, Portillo-Cuenca JC, Poyato M, Prieto L, Querol L, Rodríguez-Rodríguez E, Sarria-Estrada S, Sierra C, Soler-Palacín P, Soto-Insuga V, Toledo-Bravo L, Tomás M, Torres-Torres C, Turón E, Zabalza A (2018) Frequency, symptoms, risk factors, and outcomes of autoimmune encephalitis after herpes simplex encephalitis: a prospective observational study and retrospective analysis. Lancet Neurol 17:760–772CrossRef Armangue T, Spatola M, Vlagea A, Mattozzi S, Cárceles-Cordon M, Martinez-Heras E, Llufriu S, Muchart J, Erro ME, Abraira L, Moris G, Monros-Giménez L, Corral-Corral Í, Montejo C, Toledo M, Bataller L, Secondi G, Ariño H, Martínez-Hernández E, Juan M, Marcos MA, Alsina L, Saiz A, Rosenfeld MR, Graus F, Dalmau J, Aguilera-Albesa S, Amado-Puentes A, Arjona-Padillo A, Arrabal L, Arratibel I, Aznar-Laín G, Bellas-Lamas P, Bermejo T, Boyero-Durán S, Camacho A, Campo A, Campos D, Cantarín-Extremera V, Carnero C, Conejo-Moreno D, Dapena M, Dacruz-Álvarez D, Delgadillo-Chilavert V, Deyà A, Estela-Herrero J, Felipe A, Fernández-Cooke E, Fernández-Ramos J, Fortuny C, García-Monco JC, Gili T, González-Álvarez V, Guerri R, Guillén S, Hedrera-Fernández A, López M, López-Laso E, Lorenzo-Ruiz M, Madruga M, Málaga-Diéguez I, Martí-Carrera I, Martínez-Lacasa X, Martín-Viota L, Martín Gil L, Martínez-González MJ, Moreira A, Miranda-Herrero MC, Monge L, Muñoz-Cabello B, Navarro-Morón J, Neth O, Noguera-Julian A, Nuñez-Enamorado N, Pomar V, Portillo-Cuenca JC, Poyato M, Prieto L, Querol L, Rodríguez-Rodríguez E, Sarria-Estrada S, Sierra C, Soler-Palacín P, Soto-Insuga V, Toledo-Bravo L, Tomás M, Torres-Torres C, Turón E, Zabalza A (2018) Frequency, symptoms, risk factors, and outcomes of autoimmune encephalitis after herpes simplex encephalitis: a prospective observational study and retrospective analysis. Lancet Neurol 17:760–772CrossRef

go back to reference Desena A, Graves D, Warnack W, Greenberg BM (2014) Herpes simplex encephalitis as a potential cause of anti-N-methyl-D-aspartate receptor antibody encephalitis: report of 2 cases. JAMA Neurol 71:344–346CrossRef Desena A, Graves D, Warnack W, Greenberg BM (2014) Herpes simplex encephalitis as a potential cause of anti-N-methyl-D-aspartate receptor antibody encephalitis: report of 2 cases. JAMA Neurol 71:344–346CrossRef

go back to reference Armangue T, Leypoldt F, Málaga I, Raspall-Chaure M, Marti I, Nichter C, Pugh J, Vicente-Rasoamalala M, Lafuente-Hidalgo M, Macaya A, Ke M, Titulaer MJ, Höftberger R, Sheriff H, Glaser C, Dalmau J (2014) Herpes simplex virus encephalitis is a trigger of brain autoimmunity. Ann Neurol 75:317–323CrossRef Armangue T, Leypoldt F, Málaga I, Raspall-Chaure M, Marti I, Nichter C, Pugh J, Vicente-Rasoamalala M, Lafuente-Hidalgo M, Macaya A, Ke M, Titulaer MJ, Höftberger R, Sheriff H, Glaser C, Dalmau J (2014) Herpes simplex virus encephalitis is a trigger of brain autoimmunity. Ann Neurol 75:317–323CrossRef

go back to reference Pistacchi M, Marsala SZ, Gioulis M, Sanson F, Giometto B (2015) Uncommon relapse after post-herpes simplex encephalitis: an atypical case report. Acta Neurol Belg 115:691–695CrossRef Pistacchi M, Marsala SZ, Gioulis M, Sanson F, Giometto B (2015) Uncommon relapse after post-herpes simplex encephalitis: an atypical case report. Acta Neurol Belg 115:691–695CrossRef

go back to reference Moris G, Armangue T, Extremera VC, Conde CE, Erro ME, Rostasy K, Cuenca JCP, Turón-Viñas E, Málaga I, Muñoz-Cabello B, CarmenTorres-Torres SL, González-Gutiérrez-Solana L, González G, Casado-Naranjo I, Rosenfeld M, Graus F, Dalmau J, On behalf of the Spanish Prospective Multicentric Study of Autoimmunity in Herpes Simplex Encephalitis (2015) Autoimmune post-herpes simplex encephalitis of adults and teenagers. Neurology 85:1746–1743 Moris G, Armangue T, Extremera VC, Conde CE, Erro ME, Rostasy K, Cuenca JCP, Turón-Viñas E, Málaga I, Muñoz-Cabello B, CarmenTorres-Torres SL, González-Gutiérrez-Solana L, González G, Casado-Naranjo I, Rosenfeld M, Graus F, Dalmau J, On behalf of the Spanish Prospective Multicentric Study of Autoimmunity in Herpes Simplex Encephalitis (2015) Autoimmune post-herpes simplex encephalitis of adults and teenagers. Neurology 85:1746–1743

go back to reference Morris NA, Kaplan TB, Linnoila J, Cho T (2016) HSV encephalitis-induced anti-NMDAR encephalitis in a 67-year-old woman: report of a case and review of the literature. J Neuro-Oncol 22:33–37 Morris NA, Kaplan TB, Linnoila J, Cho T (2016) HSV encephalitis-induced anti-NMDAR encephalitis in a 67-year-old woman: report of a case and review of the literature. J Neuro-Oncol 22:33–37

go back to reference Schein F, Gagneux-Brunon A, Antoine JC, Lavernhe S, Pillet S, Paul S, Frésard A, Boutet C, Grange R, Cazorla C, Lucht F, Botelho-Nevers E (2017) Anti-N-methyl-D-aspartate receptor encephalitis after herpes simplex virus-associated encephalitis: an emerging disease with diagnosis and therapeutic challenges. Infection 45:545–549CrossRef Schein F, Gagneux-Brunon A, Antoine JC, Lavernhe S, Pillet S, Paul S, Frésard A, Boutet C, Grange R, Cazorla C, Lucht F, Botelho-Nevers E (2017) Anti-N-methyl-D-aspartate receptor encephalitis after herpes simplex virus-associated encephalitis: an emerging disease with diagnosis and therapeutic challenges. Infection 45:545–549CrossRef

go back to reference Dorcet G, Benaiteau M, Bost C, Mengelle C, Bonneville F, Martin-Blondel G, Pariente J (2020) Two cases of late-onset anti-NMDAr auto-immune encephalitis after herpes simplex virus 1 encephalitis. Front Neurol 11:38CrossRef Dorcet G, Benaiteau M, Bost C, Mengelle C, Bonneville F, Martin-Blondel G, Pariente J (2020) Two cases of late-onset anti-NMDAr auto-immune encephalitis after herpes simplex virus 1 encephalitis. Front Neurol 11:38CrossRef

go back to reference Hjalmarsson A, Blomqvist P, Sköldenberg B (2007) Herpes simplex encephalitis in Sweden, 1990-2001: incidence, morbidity, and mortality. Clin Infect Dis 45:875–880CrossRef Hjalmarsson A, Blomqvist P, Sköldenberg B (2007) Herpes simplex encephalitis in Sweden, 1990-2001: incidence, morbidity, and mortality. Clin Infect Dis 45:875–880CrossRef

go back to reference Fujinami RS, von Herrath MG, Christen U, Whitton JL (2006) Molecular mimicry, bystander activation, or viral persistence: infections and autoimmune disease. Clin Microbiol Rev 19(1):80–94CrossRef Fujinami RS, von Herrath MG, Christen U, Whitton JL (2006) Molecular mimicry, bystander activation, or viral persistence: infections and autoimmune disease. Clin Microbiol Rev 19(1):80–94CrossRef

go back to reference Pruss H, Finke C, Holtje M, Hofmann J, Klingbeil C, Probst C et al (2012) N-methyl-D-aspartate receptor antibodies in herpes simplex encephalitis. Ann Neurol 72:902–911CrossRef Pruss H, Finke C, Holtje M, Hofmann J, Klingbeil C, Probst C et al (2012) N-methyl-D-aspartate receptor antibodies in herpes simplex encephalitis. Ann Neurol 72:902–911CrossRef

go back to reference Westman G, Studahl M, Ahlm C, Eriksson BM, Persson B, Ronnelid J et al (2016) N-methyl-d-aspartate receptor autoimmunity affects cognitive performance in herpes simplex encephalitis. Clin Microbiol Infect 22:934–940CrossRef Westman G, Studahl M, Ahlm C, Eriksson BM, Persson B, Ronnelid J et al (2016) N-methyl-d-aspartate receptor autoimmunity affects cognitive performance in herpes simplex encephalitis. Clin Microbiol Infect 22:934–940CrossRef

go back to reference Malter MP, Helmstaedter C, Urbach H, Vincent A, Bien CG (2010) Antibodies to glutamic acid decarboxylase define a form of limbic encephalitis. Ann Neurol 67:470–478CrossRef Malter MP, Helmstaedter C, Urbach H, Vincent A, Bien CG (2010) Antibodies to glutamic acid decarboxylase define a form of limbic encephalitis. Ann Neurol 67:470–478CrossRef

go back to reference Xu et al (2012) CMV-associated encephalitis and antineuronal autoantibodies - a case report. BMC Neurol 12:87CrossRef Xu et al (2012) CMV-associated encephalitis and antineuronal autoantibodies - a case report. BMC Neurol 12:87CrossRef

go back to reference Niehusmann P, Widman G, Eis-Hubinger AM, Greschus S, Robens BK, Grote A et al (2016) Non-paraneoplastic limbic encephalitis and central nervous HHV-6B reactivation: causality or coincidence? Neuropathology 36:376–380CrossRef Niehusmann P, Widman G, Eis-Hubinger AM, Greschus S, Robens BK, Grote A et al (2016) Non-paraneoplastic limbic encephalitis and central nervous HHV-6B reactivation: causality or coincidence? Neuropathology 36:376–380CrossRef

go back to reference Hargrave DR, Webb DW (1998) Movement disorders in association with herpes simplex virus encephalitis in children: a review. Dev Med Child Neurol 40:640–642CrossRef Hargrave DR, Webb DW (1998) Movement disorders in association with herpes simplex virus encephalitis in children: a review. Dev Med Child Neurol 40:640–642CrossRef

go back to reference Al-Obaidi MMJ, Bahadoran A, Wang SM, Manikam R, Raju CS, Sekaran SD (2018) Disruption of the blood brain barrier is vital property of neurotropic viral infection of the central nervous system. Acta Virol 62:16–27CrossRef Al-Obaidi MMJ, Bahadoran A, Wang SM, Manikam R, Raju CS, Sekaran SD (2018) Disruption of the blood brain barrier is vital property of neurotropic viral infection of the central nervous system. Acta Virol 62:16–27CrossRef

go back to reference Titulaer MJ, McCracken L, Gabilondo I, Armangué T, Glaser C, Iizuka T, Honig LS, Benseler SM, Kawachi I, Martinez-Hernandez E, Aguilar E, Gresa-Arribas N, Ryan-Florance N, Torrents A, Saiz A, Rosenfeld MR, Balice-Gordon R, Graus F, Dalmau J (2013) Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study. Lancet Neurol 12:157–165CrossRef Titulaer MJ, McCracken L, Gabilondo I, Armangué T, Glaser C, Iizuka T, Honig LS, Benseler SM, Kawachi I, Martinez-Hernandez E, Aguilar E, Gresa-Arribas N, Ryan-Florance N, Torrents A, Saiz A, Rosenfeld MR, Balice-Gordon R, Graus F, Dalmau J (2013) Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study. Lancet Neurol 12:157–165CrossRef

go back to reference Hau L, Csábi G, Tényi T (2015) Anti-N-methyl-D aspartate receptor encephalitis guideline to the challenges of diagnosis and therapy. Psychiatr Hung 30(4):402–408PubMed Hau L, Csábi G, Tényi T (2015) Anti-N-methyl-D aspartate receptor encephalitis guideline to the challenges of diagnosis and therapy. Psychiatr Hung 30(4):402–408PubMed

go back to reference Kong SS, Chen YJ, Su IC, Lin JJ, Chou IJ, Chou ML, Hung PC, Hsieh MY, Wang YS, Chou CC, Wang HS, Lin KL, CHEESE Study Group (2019) Immunotherapy for anti-NMDA receptor encephalitis: experience from a single center in Taiwan. Pediatr Neonatol 60:417–422CrossRef Kong SS, Chen YJ, Su IC, Lin JJ, Chou IJ, Chou ML, Hung PC, Hsieh MY, Wang YS, Chou CC, Wang HS, Lin KL, CHEESE Study Group (2019) Immunotherapy for anti-NMDA receptor encephalitis: experience from a single center in Taiwan. Pediatr Neonatol 60:417–422CrossRef